+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Stents Market, Forecast to 2027

  • PDF Icon

    Report

  • 615 Pages
  • February 2021
  • Region: Global
  • IQ4I Research & Consultancy Pvt. Ltd
  • ID: 5264972
UP TO OFF until Sep 30th 2024

Global Stents Market is Expected to Reach $13.52 Billion by 2027

As estimated by the analyst, the global stents market is expected to reach $13,522.8 million by 2027, growing at a mid single digit CAGR from 2020 to 2027. The market is segmented by product, material, application, end-users and geography.

Drivers and Opportunities


  • Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm
  • Elevating Inclination Towards Minimally Invasive Therapeutic Approaches
  • The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries
  • Emergence of Technologically Advanced Products
  • Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them
  • Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish
  • Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations

Restraints and Threats


  • Stringent Regulatory Bodies Guiding Stent Manufacturers
  • The Threat of Commercialized Stent Recalls
  • Lack of Skilled, Experienced and Trained Healthcare Professionals
  • Adverse Effects of Stents
  • Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions

 

Segment Analysis

Based on the product, the stents global market is segmented into bare metal stents, drug eluting stents (DES), bioresorbable stents and other stents consisting of covered stents and the non-drug eluting polymeric stents.


  • Among these products, the drug eluting stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to increasing popularity and adoption of the highly efficient DES across the globe and the constant technological and engineering improvements in these stent products.
  • Bioresorbable stents segment is the fastest emerging segment and is expected of growing at a low teen CAGR during the forecasted period due to increasing research and development activities for the development of highly efficient and safer biodegradable stents that will gradually disappear after improving the patency of the narrowed vessel or duct.

Based on the materials used, the stents global market is segmented into metal alloy based stents and polymer based stents. The metal alloy based stents is further categorized into cobalt-chrome alloy stents, nitinol or nickel-titanium alloy stents, platinum-chromium alloy stents, stainless steel stents and other metallic biomaterial stents like those made up of magnesium, iron and others. The polymer based stents includes stents made up of durable or biostable polymers and biodegradable polymers.


  • In the overall stents market based on materials, the metal alloy based stents segment accounted for the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the increasing utilization of various metallic materials in the production of bare metal stents (BMS), drug eluting stents (DES), covered stents and even the bioresorbable stents and the exhibition of the most desirable and advantageous stent characteristics like high tensile or mechanical strength, elasticity, rigidity and radiopacity by the metallic biomaterials.
  • Among metal alloy based stents, cobalt-chrome alloy stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while nitinol alloy stents segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027.
  • Polymer based stents segment is the fastest emerging segment growing at a high single digit CAGR from 2020 to 2027 due to the escalating utilization of polymers in the manufacturing of DES, covered stents, polymeric non drug eluting stents and the polymeric bioresorbable stents and the manifestation of stent advantageous characteristics like flexibility, elasticity and the controlled drug elution kinetics by the polymers.
  • Among the different kinds of polymer based stents, durable polymer based stents segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR during the forecasted period while biodegradable polymer based stents segment is the fastest emerging segment growing at a low teen CAGR from 2020 to 2027.

Based on the application, stents global market is broadly classified as vascular and non-vascular stents.


  • Among these, the vascular stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the persistently elevating prevalence of vascular stenotic conditions and cerebral aneurysm across the globe that is in need of various rapid, efficient, technologically advanced and minimally traumatizing therapeutic interventions like stenting.
  • The vascular stents are further segmented into coronary artery stents, peripheral artery stents, neurovascular stents and others consisting of venous stents, vertebral artery stents and pulmonary artery stents. Among these, the coronary artery stent segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while neurovascular stents segment is the fastest emerging segment and is expected of growing at a high single digit CAGR from 2020 to 2027.
  • Neurovascular stents can be further classified into carotid artery stents, intracranial stents and flow diverter stents for treating cerebral aneurysms. Among the various neurovascular stents, carotid artery stents accounted for the largest revenue in 2020 and is expected to grow at double digit CAGR during 2020 to 2027.
  • Based on the application type, non-vascular stents are segmented into gastrointestinal stents, urinary tract stents or urological stents, airway or tracheobronchial stents or pulmonary stents and others consisting of ophthalmic stents. Among these, the gastrointestinal stents (GI) segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027.
  • GI stents are further segmented as pancreatic and biliary stents, colonic or colorectal stents, esophageal stents and duodenal stents. Among these, the Pancreatic & Biliary Stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.

Based on the end-users, the stents global market is divided into Hospitals; Ambulatory surgery centers (ASCs) and others consisting of Freestanding or mobile Catheterization Labs and Research Institutes.


  • Among the various end-users, Hospitals segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR during the period 2020 to 2027 due to increased utilization of various types of stent products for the stenting procedures performed in the hospital associated in-patient or out-patient settings.
  • Ambulatory Surgery Centers (ASCs) segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027.

Based on the region, the stents global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Turkey, Rest of Latin America and Middle East & Africa).


  • The major share of the stents global market is occupied by Asia-Pacific in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 mainly due to the persistently elevating prevalence of vascular and non-vascular stenotic conditions in the region, increasing affordability and accessibility of the major stent products like coronary stents among the patients of some of the major countries in the region attributed to government imposed price slashing measures for these life-saving devices, elevating geriatric population impaired with various kinds of vascular or non-vascular obstructive diseases, increasing patient awareness and demand for better, quick minimally invasive, efficient therapeutic procedures with advanced therapeutic products, growing economies of the region, persistently developing healthcare infrastructural facilities in the region, increasing healthcare expenditures and medical tourism aspects of the region.
  • Rest of World (RoW) is the fastest emerging region and is expected of growing at a high single digit CAGR during the forecasted period. The rapid market growth rate of stents market in this region is due to escalating prevalence of vasculature and duct system associated obstructive conditions in the region, increasing geriatric population loaded with various kinds of stenotic conditions, increasing patient awareness and demand for better, quick minimally invasive therapeutic procedures and efficient therapeutic products, growing economies of the region, increasing per capita expenditure on healthcare needs and medical tourism prospects of the region.

Competitive Landscape

The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co. KG (Germany), Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.) (China) and others.

Global Stents Market Share by Key Players, 2020 (%)

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:


  • North America
    • U.S.
    • Rest of North America

  • Europe
    • Germany
    • France
    • Italy
    • Rest of Europe

  • Asia-Pacific 
    • China
    • Japan
    • India
    • Rest of APAC

  • Rest of the World (RoW)
    • Brazil
    • Turkey
    • Rest of LATAM and Middle East & Africa

 


Table of Contents

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown and Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points from Secondary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm
3.3.1.2 Elevating Inclination Towards Minimally Invasive Therapeutic Approaches
3.3.1.3 The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries
3.3.1.4 Emergence of Technologically Advanced Products
3.3.1.5 Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them
3.3.1.6 Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish
3.3.1.7 Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations
3.3.2 Restraints and Threats
3.3.2.1 Stringent Regulatory Bodies Guiding Stent Manufacturers
3.3.2.2 The Threat of Commercialized Stent Recalls
3.3.2.3 Lack of Skilled, Experienced and Trained Healthcare Professionals
3.3.2.4 Adverse Effects of Stents
3.3.2.5 Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 14644-1 Clean Room Standards
3.4.1.3 ISO 13485 Medical Devices
3.4.1.4 ISO 10993 Biological Evaluation of Medical Devices
3.4.1.5 ISO 14971: Risk Management of Medical Devices
3.4.1.6 ISO 25539-2: 2020 Cardiovascular Implants - Endovascular Devices - Part 2: Vascular Stents
3.4.1.7 ISO 25539-1
3.4.1.8 ISO 12417-1
3.4.1.9 ISO/TS 17137
3.4.1.10 ISO 17327-1
3.4.1.11 IEC 60601-1 Medical Electrical Equipment Standard
3.4.2 ASTM International Standards
3.4.3 U.S.
3.4.4 Canada
3.4.5 Europe
3.4.6 Japan
3.4.7 China
3.4.8 India
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Smart Stents
3.5.3 3D-Printed Stents
3.5.4 Indirect 4D Printing and Microstents
3.5.5 Nanocoated Non-Drug Eluting Stent and Ultrashort DAPT
3.5.6 Bioengineered Stents
3.5.7 Gene Eluting Stents (GES)
3.5.8 Bioresorbable Stents
3.6 Stents Coating Materials
3.6.1 Inorganic Coating Materials
3.6.2 Organic Coating Materials
3.6.3 Biological Coating Materials or Biocoatings
3.6.4 Chemotheraputics or Drugs
3.7 Porter’s Five Force Analysis
3.7.1 Threat of New Entrants
3.7.2 Threat of Substitutes
3.7.3 Bargaining Power of Suppliers
3.7.4 Bargaining Power of Buyers
3.7.5 Competitive Rivalry
3.8 Supply Chain Analysis
3.9 Reimbursement Scenario
3.10 Patent Trends
3.11 Regulatory Approval Analysis
3.12 Clinical Trials
3.13 Market Share Analysis by Major Players
3.13.1 Stents Global Market Share Analysis
3.13.2 Coronary Stents Global Market Share Analysis
3.13.3 Peripheral Stents Global Market Share Analysis
3.13.4 Neurovascular Stents Global Market Share Analysis
3.13.4.1 Flow Diverters Global Market Share Analysis
3.13.4.2 Intracranial Stent Global Market Share Analysis
3.13.4.3 Carotid Stent Global Market Share Analysis
3.13.5 Gastrointestinal Stents Global Market Share Analysis
3.13.6 Drug Eluting Stents Global Market Share Analysis
3.14 Stents - Number of Procedures by Region
3.14.1 Coronary Stent Implantation Procedural Volume by Region
3.14.2 Peripheral Stent Implantation Procedural Volume by Region
3.15 Stents Company Comparison Table by Revenue, Product, Product Type, Application, Material and Indication

4 Stents Global Market, by Product
4.1 Introduction
4.2 Bare Metal Stents
4.3 Drug Eluting Stents
4.4 Bioresorbable Stents
4.5 Other Stents

5 Stents Global Market, by Material
5.1 Introduction
5.2 Metal Alloy Based Stents
5.2.1 Cobalt Chrome Alloy Stents
5.2.2 Nitinol Alloy Stents
5.2.3 Stainless Steel Stents
5.2.4 Platinum Alloy Stents
5.2.5 Other Metal Alloy Stents
5.3 Polymer Based Stents
5.3.1 Durable Polymer Stents
5.3.2 Biodegradable Polymer Stents

6 Stents Global Market, by Application
6.1 Introduction
6.2 Vascular Stents
6.2.1 Coronary Artery Stents
6.2.2 Peripheral Artery Stents
6.2.3 Neurovascular Stents
6.2.3.1 Carotid Artery Stents
6.2.3.2 Intracranial Stents
6.2.3.3 Flow Diverter Stents
6.2.4 Renal Artery Stents
6.2.5 Other Vascular Stents
6.3 Non-Vascular Stents
6.3.1 Gastrointestinal Stents
6.3.1.1 Pancreatic & Biliary Stents
6.3.1.2 Colorectal Stents
6.3.1.3 Esophageal Stents
6.3.1.4 Duodenal Stents
6.3.2 Urological Stents
6.3.3 Airway Stents
6.3.4 Other Non-Vascular Stents

7 Stents Global Market, by End-users
7.1 Introduction
7.2 Hospitals
7.3 Ambulatory Surgery Centers
7.4 Other End-users

8 Regional Analysis
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Rest of North America
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Italy
8.3.4 Rest of Europe
8.4 APAC
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of APAC
8.5 Rest of the World
8.5.1 Brazil
8.5.2 Turkey
8.5.3 Rest of LATAM and MEA

9 Competitive Landscape
9.1 Introduction
9.2 Product Approval
9.3 Clinical Studies/Investigations
9.4 Product Launch
9.5 Acquisition
9.6 Other Developments

10 Major Companies
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Key Developments
10.2.5 Business Strategy
10.2.6 SWOT Analysis
10.3 Becton, Dickinson and Company
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Key Developments
10.3.5 Business Strategy
10.3.6 SWOT Analysis
10.4 Biotronik SE & Co. KG
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Key Developments
10.4.5 Business Strategy
10.4.6 SWOT Analysis
10.5 Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.)
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Key Developments
10.5.5 Business Strategy
10.5.6 SWOT Analysis
10.6 Boston Scientific Corporation
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Developments
10.6.5 Business Strategy
10.6.6 SWOT Analysis
10.7 Cardinal Health Inc.
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Key Developments
10.7.5 Business Strategy
10.7.6 SWOT Analysis
10.8 Cook Medical LLC
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Developments
10.8.5 Business Strategy
10.8.6 SWOT Analysis
10.9 Medtronic plc
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Key Developments
10.9.5 Business Strategy
10.9.6 SWOT Analysis
10.10 Terumo Corporation
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Key Developments
10.10.5 Business Strategy
10.10.6 SWOT Analysis

List of Tables
Table 1 Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 2 Average Selling Price (ASP) of Bare Metal Stents, Drug Eluting Stents, Covered Stents and Bioresorbable Stents (2020) ($)
Table 3 Coronary Stent Implantation Procedures, by Region, (2019-2027) (No’s)
Table 4 Peripheral Stent Implantation Procedures, by Region, (2019-2027) (No’s)
Table 5 Stents Global Market Revenue, by Product, (2019-2027) ($Mn)
Table 6 Bare Metal Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 7 Drug Eluting Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 8 Bioresorbable Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 9 Other Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 10 Stents Global Market Revenue, by Material, (2019-2027) ($Mn)
Table 11 Metal Alloy Based Stents Global Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 12 Metal Alloy Based Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 13 Cobalt Chrome Alloy Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 14 Nitinol Alloy Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 15 Stainless Steel Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 16 Platinum Alloy Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 17 Other Metal Alloy Based Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 18 Polymer Based Stents Global Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 19 Polymer Based Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 20 Durable Polymer Based Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 21 Biodegradable Polymer Based Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 22 Stents Global Market Revenue, by Application, (2019-2027) ($Mn)
Table 23 Vascular Stents Global Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 24 Vascular Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 25 Coronary Artery Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 26 Peripheral Artery Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 27 Neurovascular Stents Global Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 28 Neurovascular Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 29 Carotid Artery Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 30 Intracranial Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 31 Flow Diverters Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 32 Renal Artery Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 33 Other Vascular Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 34 Non-Vascular Stents Global Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 35 Non-Vascular Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 36 Gastrointestinal Stents Global Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 37 Gastrointestinal Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 38 Pancreatic & Biliary Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 39 Colorectal Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 40 Esophageal Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 41 Duodenal Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 42 Urological Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 43 Airway Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 44 Other Non-Vascular Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 45 Stents Global Market Revenue, by End-users, (2019-2027) ($Mn)
Table 46 Hospitals Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 47 Ambulatory Surgery Centers Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 48 Other End-users Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 49 Stents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 50 North America Stents Market Revenue, by Product, (2019-2027) ($Mn)
Table 51 North America Stents Market Revenue, by Material, (2019-2027) ($Mn)
Table 52 North America Metal Alloy Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 53 North America Polymer Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 54 North America Stents Market Revenue, by Application, (2019-2027) ($Mn)
Table 55 North America Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 56 North America Neurovascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 57 North America Non-Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 58 North America Gastrointestinal Stents Market Revenue, by Application Type (2019-2027) ($Mn)
Table 59 North America Stents Market Revenue, by End-users (2019-2027) ($Mn)
Table 60 North America Stents Market Revenue, by Country, (2019-2027) ($Mn)
Table 61 Europe Stents Market Revenue, by Product, (2019-2027) ($Mn)
Table 62 Europe Stents Market Revenue, by Material, (2019-2027) ($Mn)
Table 63 Europe Metal Alloy Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 64 Europe Polymer Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 65 Europe Stents Market Revenue, by Application, (2019-2027) ($Mn)
Table 66 Europe Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 67 Europe Neurovascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 68 Europe Non-Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 69 Europe Gastrointestinal Stents Market Revenue, by Application Type (2019-2027) ($Mn)
Table 70 Europe Stents Market Revenue, by End-users (2019-2027) ($Mn)
Table 71 Europe Stents Market Revenue, by Country, (2019-2027) ($Mn)
Table 72 APAC Stents Market Revenue, by Product, (2019-2027) ($Mn)
Table 73 APAC Stents Market Revenue, by Material, (2019-2027) ($Mn)
Table 74 APAC Metal Alloy Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 75 APAC Polymer Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 76 APAC Stents Market Revenue, by Application, (2019-2027) ($Mn)
Table 77 APAC Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 78 APAC Neurovascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 79 APAC Non-Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 80 APAC Gastrointestinal Stents Market Revenue, by Application Type (2019-2027) ($Mn)
Table 81 APAC Stents Market Revenue, by End-users (2019-2027) ($Mn)
Table 82 APAC Stents Market Revenue, by Country, (2019-2027) ($Mn)
Table 83 RoW Stents Market Revenue, by Product, (2019-2027) ($Mn)
Table 84 RoW Stents Market Revenue, by Material, (2019-2027) ($Mn)
Table 85 RoW Metal Alloy Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 86 RoW Polymer Based Stents Market Revenue, by Material Type, (2019-2027) ($Mn)
Table 87 RoW Stents Market Revenue, by Application, (2019-2027) ($Mn)
Table 88 RoW Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 89 RoW Neurovascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 90 RoW Non-Vascular Stents Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 91 RoW Gastrointestinal Stents Market Revenue, by Application Type (2019-2027) ($Mn)
Table 92 RoW Stents Market Revenue, by End-users (2019-2027) ($Mn)
Table 93 RoW Stents Market Revenue, by Country, (2019-2027) ($Mn)
Table 94 Product Approval (2019-2020)
Table 95 Clinical Studies/Investigations (2019-2020)
Table 96 Product Launch (2019-2020)
Table 97 Acquisition (2019-2020)
Table 98 Other Developments (2019-2020)
Table 99 Abbott Laboratories: Total Revenue and R&D Expenses (2018-2020) ($Mn)
Table 100 Abbott Laboratories: Total Revenue, by Segments (2018-2020) ($Mn)
Table 101 Abbott Laboratories: Medical Device Revenue, by Sub-Segments (2018-2020) ($Mn)
Table 102 Abbott Laboratories: Total Revenue, by Geography (2018-2020) ($Mn)
Table 103 B.Braun Melsungen: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 104 B.Braun Melsungen: Total Revenue, by Segments, (2017-2019) ($Mn)
Table 105 B.Braun Melsungen: Total Revenue By, Geography, (2017-2019) ($Mn)
Table 106 Becton, Dickinson and Company: Total Revenue and R&D Expenses, (2018-2020) ($Mn)
Table 107 Becton, Dickinson and Company: Total Revenue by Product Segments, (2018-2020) ($Mn)
Table 108 Becton, Dickinson and Company: Interventional Revenue, by Sub-Segments, (2018-2020) ($Mn)
Table 109 Becton, Dickinson and Company: Total Revenue by Geography, (2018-2020) ($Mn)
Table 110 Boston Scientific Corporation: Total Revenue and R&D Expenses (2018-2020) ($Mn)
Table 111 Boston Scientific Corporation: Total Revenue, by Segment, (2018-2020) ($Mn)
Table 112 Boston Scientific Corporation: Cardiovascular Revenue by Sub-Segments, (2018-2020) ($Mn)
Table 113 Boston Scientific Corporation: Medsurg Revenue by Sub-Segments, (2018-2020) ($Mn)
Table 114 Boston Scientific Corporation: Total Revenue, by Geography, (2018-2020) ($Mn)
Table 115 Cardinal Health: Total Revenue and R&D Expenses, (2019-2021) ($Mn)
Table 116 Cardinal Health: Total Revenue, by Segments (2019-2021) ($Mn)
Table 117 Cardinal Health: Medical Revenue, by Sub-Segments, (2019-2021) ($Mn)
Table 118 Cardinal Health: Total Revenue, by Geography, (2019-2021) ($Mn)
Table 119 Medtronic plc: Total Sales and R&D Expenses, (2018-2020) ($Mn)
Table 120 Medtronic plc: Total Sales, by Segments, (2018-2020) ($Mn)
Table 121 Medtronic plc: Cardiac and Vascular Group Revenue, by Sub-Segments, (2018-2020) ($Mn)
Table 122 Medtronic plc: Restorative Therapies Group Revenue, by Sub-Segments, (2018-2020) ($Mn)
Table 123 Medtronic plc: Total Sales, by Geography, (2018-2020)($Mn)
Table 124 Terumo Corporation: Total Revenue and R&D Expenses, (2018-2020) ($Mn)
Table 125 Terumo Corporation: Total Revenue, by Product Segments, (2018-2020) ($Mn)
Table 126 Terumo Corporation: Total Revenue, by Geography, (2018-2020) ($Mn)

List of Figures
Figure 1 Stents Global Market Revenue, by Region (2019-2027) ($Mn)
Figure 2 Research Methodology: Stents Global Market
Figure 3 Stents Global Market: Top-Down and Bottom-Up Approach
Figure 4 Stents Global Market: Forecasting Model
Figure 5 Stents Global Market: Market Breakdown and Data Triangulation
Figure 6 Stents Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Stents Global Market: Porter’s Analysis
Figure 9 Stents: Supply Chain Analysis
Figure 10 Stents Global Market: Patent Filing by Major Players (2016-2021)
Figure 11 Stents Clinical Trial Analysis
Figure 12 Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 13 Coronary Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 14 Peripheral Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 15 Neurovascular Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 16 Flow Diverters Global Market Share Analysis, by Key Players, 2020 (%)
Figure 17 Intracranial Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 18 Carotid Stent Global Market Share Analysis, by Key Players, 2020 (%)
Figure 19 Gastrointestinal Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 20 Drug Eluting Stents Global Market Share Analysis, by Key Players, 2020 (%)
Figure 21 Stents Global Market Share, by Product (2020 vs 2027) (%)
Figure 22 Stents Global Market Share, by Material (2020 vs 2027) (%)
Figure 23 Metal Alloy Based Stents Global Market Share, by Material Type (2020 vs 2027) (%)
Figure 24 Polymer Based Stents Global Market Share, by Material Type (2020 vs 2027) (%)
Figure 25 Durable Polymer Based Stents Global Market Share, by Region (2020 vs 2027) (%)
Figure 26 Stents Global Market Share, by Application (2020 vs 2027) (%)
Figure 27 Vascular Stents Global Market Share, by Application Type (2020 vs 2027) (%)
Figure 28 Neurovascular Stents Global Market Share, by Application Type (2020 vs 2027) (%)
Figure 29 Intracranial Stents Global Market Share, by Region (2020 vs 2027) (%)
Figure 30 Non-Vascular Stents Global Market Share, by Application Type (2020 vs 2027) (%)
Figure 31 Non-Vascular Stents Global Market Share, by Region (2020 vs 2027) (%)
Figure 32 Gastrointestinal Stents Global Market Share, by Application Type (2020 vs 2027) (%)
Figure 33 Esophageal Stents Global Market Share, by Region (2020 vs 2027) (%)
Figure 34 Stents Global Market Share, by End-users (2020 vs 2027) (%)
Figure 35 Stents Global Market Revenue, by Region (2019-2027) ($Mn), CAGR (%)
Figure 36 Stents Global Market Share by Region and Market Revenue by Country, (2020) (%)
Figure 37 North America Stents Market Share, by Product (2020 vs 2027) (%)
Figure 38 North America Stents Market Share, by Material and Metal Alloy & Polymer Stents by Material Type (2020 vs 2027) (%)
Figure 39 North America Stents Market Share, by Application (2020 vs 2027) % and Vascular & Non-Vascular Stents by Application Type (2020) (%)
Figure 40 North America Stents Market Share, by End-users (2020 vs 2027) (%)
Figure 41 North America Stents Market Share, by Country (2020 vs 2027) (%)
Figure 42 U.S. Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 43 U.S. Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 44 Rest of North America Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 45 Rest of North America Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 46 Europe Stents Market Share, by Product (2020 vs 2027) (%)
Figure 47 Europe Stents Market Share, by Material and Metal Alloy & Polymer Stents by Material Type (2020 vs 2027) (%)
Figure 48 Europe Stents Market Share, by Application (2020 vs 2027) % and Vascular & Non-Vascular Stents by Application Type (2020) (%)
Figure 49 Europe Stents Market Share, by End-users (2020 vs 2027) (%)
Figure 50 Europe Stents Market Share, by Country (2020 vs 2027) (%)
Figure 51 Germany Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 52 Germany Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 53 France Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 54 France Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 55 Italy Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 56 Italy Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 57 Rest of Europe Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 58 Rest of Europe Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 59 APAC Stents Market Share, by Product (2020 vs 2027) (%)
Figure 60 APAC Stents Market Share, by Material and Metal Alloy & Polymer Stents by Material Type (2020 vs 2027) (%)
Figure 61 APAC Stents Market Share, by Application (2020 vs 2027) % and Vascular & Non-Vascular Stents by Application Type (2020) (%)
Figure 62 APAC Stents Market Share, by End-users (2020 vs 2027) (%)
Figure 63 APAC Stents Market Share, by Country (2020 vs 2027) (%)
Figure 64 China Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 65 China Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 66 Japan Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 67 Japan Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 68 India Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 69 India Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 70 Rest of APAC Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 71 Rest of APAC Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 72 RoW Stents Market Share, by Product (2020 vs 2027) (%)
Figure 73 RoW Stents Market Share, by Material and Metal Alloy & Polymer Stents by Material Type (2020 vs 2027) (%)
Figure 74 RoW Stents Market Share, by Application (2020 vs 2027) % and Vascular & Non-Vascular Stents by Application Type (2020) (%)
Figure 75 RoW Stents Market Share, by End-users (2020 vs 2027) (%)
Figure 76 RoW Stents Market Share, by Country (2020 vs 2027) (%)
Figure 77 Brazil Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 78 Brazil Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 79 Turkey Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 80 Turkey Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 81 Rest of LATAM and MEA Stents Market Revenue, by Product, Material, Application and End-users (2020 vs 2027) ($Mn)
Figure 82 Rest of LATAM and MEA Vascular and Non-Vascular Stents Market Revenue, by Application Type (2020 vs 2027) ($Mn)
Figure 83 Key Developments (2019 -2020)
Figure 84 SWOT: Abbott Laboratories
Figure 85 SWOT: B. Braun Melsungen
Figure 86 SWOT: Becton, Dickinson and Company
Figure 87 SWOT: Biotronik SE & Co. KG
Figure 88 SWOT: Blue Sail Medical Co. Ltd.
Figure 89 SWOT: Boston Scientific Corporation
Figure 90 SWOT: Cardinal Health
Figure 91 SWOT: Cook Medical Incorporated
Figure 92 SWOT: Medtronic plc
Figure 93 SWOT: Terumo Corporation


Samples

Loading
LOADING...

Executive Summary

Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them.

Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel’s or duct’s natural function.

Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient’s condition quickly through efficient and safer interventional products are fuelling the stents global market.


Companies Mentioned

  • Abbott Laboratories
  • Abbvie Inc.
  • Acandis GmbH
  • Accura Medizintechnik GmbH
  • Allium Ltd.
  • Alvimedica
  • AndraTec GmbH
  • Arterius Limited
  • B. Braun Melsungen AG
  • B.Braun Melsungen AG
  • Balt Extrusion
  • Balton Sp. z o.o.
  • Becton, Dickinson and Company
  • Bentley InnoMed GmbH
  • Bess AG
  • Bioteque Corporation
  • Biotronik SE & Co. KG
  • Blue Sail Medical Co. Ltd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • CeloNova BioSciences, Inc.
  • Conmed Corporation
  • Cook Medical LLC
  • Disa Vascular
  • Dispomedica GmbH
  • Elixir Medical Corporation
  • ELLA - CS, s.r.o
  • Endocor GmbH
  • EndoGI Medical
  • Eucatech AG
  • EuroCor Tech GmbH
  • GENOSS Co. Ltd.
  • Glaukos Corporation
  • Hexacath International
  • HydrUStent SA
  • InspireMD
  • Ivantis Inc.
  • iVascular S.L.U.
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology
  • M.I.TECH Co. Ltd.
  • Med pro Medical B.V.
  • Medas Inc.
  • Medicut Stent Technology GmbH
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems Inc.
  • Merlin MD Pte. Ltd.
  • Micell Technologies, Inc.
  • Micro Science Medical AG
  • Micro-Tech
  • Microport Scientific Corporation
  • Nanostent
  • Numed Inc.
  • Olympus Corporation
  • Optimed Medizinische Instrumente GmbH
  • Opto Circuits
  • OrbusNeich Medical Company Limited
  • Palex Medical SA
  • Phenox GmbH
  • Plus medica Nordic AB
  • PNN Medical A/S
  • Poseidon Medical Inc.
  • Q3 Medical Devices Ltd.
  • Relisys Medical Devices Limited
  • REVA Medical Inc.
  • Rontis AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Scitech Produtos Médicos SA
  • Silk Road Medical Inc.
  • Stening Srl
  • Svelte Medical Systems Inc.
  • Synlas GmbH & Co. KG
  • Taewoong Medical Co. Ltd.
  • Terumo Corporation
  • Thoracent, Inc.
  • Translumina Therapeutics
  • USM Healthcare Medical Devices Factory JSC
  • Vygon SA
  • W. L. Gore & Associates, Inc.
  • Wellinq Holding B.V.
  • Zhejiang Chuangxiang Medical Technology Co. Ltd.